IntraBio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2B

IntraBio General Information

Description

Developer of novel therapies designed for the treatment of rare and neurodegenerative diseases with high unmet medical needs. The company's technology includes small molecule drugs for lysosomal storage disorders and orphan indications, enabling healthcare providers to offer specialized treatments for patients with life-threatening genetic conditions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 201 West 5th Street
  • Suite 1100
  • Austin, TX 78701
  • United States
+1 (833)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 201 West 5th Street
  • Suite 1100
  • Austin, TX 78701
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IntraBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 18-Nov-2026 $2B Completed Generating Revenue
4. Later Stage VC 23-Mar-2024 Completed Generating Revenue
3. Later Stage VC (Series C) 05-Apr-2023 Completed Clinical Trials - Phase 3
2. Later Stage VC 05-Nov-2020 $10.3M $10.3M Completed Clinical Trials - Phase 3
1. Early Stage VC 01-Jul-2017 Completed Clinical Trials - Phase 3
To view IntraBio’s complete valuation and funding history, request access »

IntraBio Patents

IntraBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236588-A2 Modulation of transcription factor eb activity by n-acetyl leucine to treat disorders Pending 09-May-2025
US-20260097008-A1 Acetyl leucine for use in treating niemann-pick disease type c Pending 07-Oct-2024
WO-2025264957-A2 Acetyl leucine for treating neurodevelopmental disorders Pending 20-Jun-2024
WO-2025264957-A3 Acetyl leucine for treating neurodevelopmental disorders Pending 20-Jun-2024
AU-2025223718-A1 Acetyl leucine for treating syngap1-related disorders Pending 14-Feb-2024 A61P21/00
To view IntraBio’s complete patent history, request access »

IntraBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IntraBio Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biohealth Innovation Corporation Minority
Oxford Science Enterprises Venture Capital Minority
To view IntraBio’s complete investors history, request access »

IntraBio FAQs

  • When was IntraBio founded?

    IntraBio was founded in 2015.

  • Where is IntraBio headquartered?

    IntraBio is headquartered in Austin, TX.

  • What is the size of IntraBio?

    IntraBio has 5 total employees.

  • What industry is IntraBio in?

    IntraBio’s primary industry is Drug Discovery.

  • Is IntraBio a private or public company?

    IntraBio is a Private company.

  • What is the current valuation of IntraBio?

    The current valuation of IntraBio is .

  • What is IntraBio’s current revenue?

    The current revenue for IntraBio is .

  • How much funding has IntraBio raised over time?

    IntraBio has raised $65.6M.

  • Who are IntraBio’s investors?

    Biohealth Innovation and Oxford Science Enterprises have invested in IntraBio.

  • When was IntraBio acquired?

    IntraBio was acquired on 18-Nov-2026.

  • Who acquired IntraBio?

    IntraBio was acquired by Shionogi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process